The new clinical integration system at New York-Presbyterian/Weill Cornell Medical Center’s level IV neonatal intensive care unit (NICU) is ringing all the right alarms.

Critically-ill, preterm infants with rare, genetic diseases are a notoriously difficult group to diagnose. Genome-wide testing during the newborn period may have a profound impact on clinical decision-making, which may make all the difference for a family with a sick baby.

In a recent review of continuous noninvasive monitoring in the NICU published in Current Opinion in Pediatrics, Dr. Rakesh Sahni provides an overview on the clinical use of pulse oximetry as a method for assessing end-organ oxygenation.

Each year, some 9,500 premature infants die in Tanzania. Dr. Jeffrey M. Perlman, MB has marshalled efforts to facilitate a low-cost, evidence-based preventative strategy to combat infant mortality in the developing world.